Search

everythinglearnresearchcommunity

for

Search:↓

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

3D printing can make microneedles for drug delivery faster and cheaper.

Swellable microneedles could improve drug delivery and diagnostics but need more research on materials and technology integration.

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

Drug repositioning can save time and money but needs more support.

Drug repositioning offers a cost-effective, lower-risk way to treat diseases and pandemics like COVID-19.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Nanoformulations improve drug delivery through the skin, reducing side effects and enhancing effectiveness.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.

Drug repurposing offers promising strategies to improve tuberculosis treatment despite challenges.

Nanocarriers show promise for improving skin drug delivery in treating skin conditions.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Microneedles in wearables can deliver drugs over time but face challenges in manufacturing and safety.

EV-based drug delivery shows promise but faces challenges in standardization and scalability.

Microneedles improve drug delivery for skin diseases, enhancing treatment effectiveness and patient compliance.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Drug repurposing speeds up development, cuts costs, and uses known safe drugs, but faces challenges like regulations and patents.

Scaffold-based drug delivery systems improve oral cancer treatment by targeting drugs directly to cancer cells, reducing side effects.

Advanced hydrogels can autonomously deliver drugs to treat radiation skin injuries, but challenges remain for clinical use.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

Old psychiatric drugs are increasingly being used for new purposes, and technologies like SmartCube® help create new drugs.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

A blood pressure drug, diltiazem, may also help treat influenza.

Data-driven methods can effectively identify existing drugs for new uses, especially in cancer, infections, and respiratory diseases.

Solid lipid nanoparticles are promising for safe and effective drug delivery but need more research for clinical use.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.